Bank of Montreal’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-17,319
Closed -$362K – 4593
2022
Q3
$362K Buy
17,319
+6,308
+57% +$131K ﹤0.01% 2805
2022
Q2
$228K Sell
11,011
-17,265
-61% -$307K ﹤0.01% 3191
2022
Q1
$487K Buy
28,276
+5
+0% +$87 ﹤0.01% 2872
2021
Q4
$566K Sell
28,271
-2,619
-8% -$49.3K ﹤0.01% 2304
2021
Q3
$563K Sell
30,890
-1,087
-3% -$24.9K ﹤0.01% 2808
2021
Q2
$892K Sell
31,977
-2,862
-8% -$80.1K ﹤0.01% 2554
2021
Q1
$1.02M Sell
34,839
-4,028
-10% -$137K ﹤0.01% 2177
2020
Q4
$1.27M Buy
38,867
+22,088
+132% +$596K ﹤0.01% 2081
2020
Q3
$432K Sell
16,779
-1,413
-8% -$30.5K ﹤0.01% 2393
2020
Q2
$346K Buy
18,192
+16,658
+1,086% +$219K ﹤0.01% 2457
2020
Q1
$12K Sell
1,534
-5,445
-78% -$62.2K ﹤0.01% 3438
2019
Q4
$92K Sell
6,979
-3,376
-33% -$40.9K ﹤0.01% 3544
2019
Q3
$125K Sell
10,355
-5,530
-35% -$102K ﹤0.01% 3184
2019
Q2
$388K Sell
15,885
-135,318
-89% -$3.9M ﹤0.01% 2569
2019
Q1
$4.82M Buy
+151,203
New +$5.37M ﹤0.01% 1188

Other funds holding CVET

Bank of Montreal's CVET Position: Q4 2022 in Review

Bank of Montreal sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 17,319 shares — an estimated $362K sold.

Bank of Montreal first reported a position in CVET in Q1 2019 and held it in 15 quarters. The position peaked at $4.82M in Q1 2019. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • Bank of Montreal reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Bank of Montreal sold 17,319 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $362K.
  • Bank of Montreal first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 15 quarters.
  • Bank of Montreal's Covetrus, Inc. Common Stock position peaked at $4.82M in Q1 2019.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Bank of Montreal's 13F filing for Q4 2022, filed 1 Feb 2023.